{
  "abnormal_motor_posturing": {
    "title": "Abnormal Motor Posturing",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Motor Signs"
    ],
    "content": {
      "definition": "<p><b>Abnormal motor posturing</b> refers to involuntary, reflexive flexion or extension of the limbs in comatose patients, indicating severe brain injury and serving as a clinical marker for the <u>level of brainstem damage</u> (above or below the red nucleus).</p>",
      "atAGlance": "<ul><li><b>Decorticate (Flexor):</b> Arms flexed/adducted (hands like 'C's moving toward the 'Cord'), legs extended. Indicates lesion <u>above</u> the [[red_nucleus]] (e.g., cerebral hemispheres, internal capsule).</li><li><b>Decerebrate (Extensor):</b> Arms extended/pronated, legs extended. Indicates lesion <u>at or below</u> the [[red_nucleus]] (e.g., midbrain, upper pons).</li><li><b>Prognosis:</b> Decerebrate posturing generally indicates more severe brainstem damage and a worse prognosis than decorticate.</li><li><b>Pathophysiology:</b> Disinhibition of the [[rubrospinal_tract]] (flexion) vs. dominance of the [[vestibulospinal_tract]] (extension).</li><li><b>USMLE Tip:</b> Remember: De<b>cor</b>ticate = Hands near the <b>Cor</b> (Heart).</li></ul>",
      "takeAway": "<p><b>Abnormal motor posturing</b> distinguishes the level of brain injury: <b>Decorticate</b> (flexor) implies hemispheric damage sparing the red nucleus, while <b>Decerebrate</b> (extensor) implies deeper brainstem damage affecting the red nucleus.</p>",
      "mermaid": "graph TD; A[Brain Injury] --> B{Lesion Location?}; B -->|Above Red Nucleus| C[Decorticate Posturing]; B -->|At/Below Red Nucleus| D[Decerebrate Posturing]; C --> E[Flexor Tone Dominates]; D --> F[Extensor Tone Dominates];"
    },
    "connections": [
      {
        "type": "indicates_lesion_at",
        "to": "red_nucleus"
      },
      {
        "type": "involves_pathway",
        "to": "rubrospinal_tract"
      },
      {
        "type": "involves_pathway",
        "to": "vestibulospinal_tract"
      }
    ]
  },
  "absence_seizure": {
    "title": "Absence Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Generalized Seizures"
    ],
    "content": {
      "definition": "<p><b>Absence seizures</b> (formerly petit mal) are a type of <i>generalized seizure</i> primarily affecting children, characterized by sudden, brief lapses of consciousness (\"staring spells\") without loss of postural tone or postictal confusion, associated with a distinct <u>3 Hz spike-and-wave</u> EEG pattern.</p>",
      "atAGlance": "<ul><li><b>Clinical Presentation:</b> Sudden behavioral arrest (staring), eyelid fluttering, or automatisms (lip smacking); lasts ~10 seconds; immediate return to baseline (no postictal state).</li><li><b>Triggers:</b> Often provoked by <mark>hyperventilation</mark>.</li><li><b>EEG:</b> Classic generalized <b>3 Hz spike-and-wave</b> discharges.</li><li><b>Treatment:</b> First-line is [[ethosuximide]] (blocks T-type Ca<sup>2+</sup> channels); [[valproate]] is second-line (especially if co-occurring tonic-clonic seizures).</li><li><b>USMLE Tip:</b> Differentiate from [[focal_impaired_awareness_seizure]] (complex partial) which <i>does</i> have a postictal state and lasts longer.</li></ul>",
      "takeAway": "<p><b>Absence seizures</b> are pediatric generalized seizures defined by brief staring spells and a pathognomonic <mark>3 Hz spike-and-wave</mark> EEG, uniquely treated with [[ethosuximide]].</p>",
      "mermaid": "graph TD; A[Thalamocortical Circuitry] --> B[Abnormal Oscillation]; B --> C[3 Hz Spike-and-Wave]; C --> D[Brief Loss of Awareness]; D --> E[No Postictal Confusion];"
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "ethosuximide"
      },
      {
        "type": "treated_by",
        "to": "valproate"
      },
      {
        "type": "is_distinguished_from",
        "to": "focal_impaired_awareness_seizure"
      },
      {
        "type": "manifests_as",
        "to": "staring_spell"
      }
    ]
  },
  "ethosuximide": {
    "title": "Ethosuximide",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Anticonvulsants",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Ethosuximide</b> is a narrow-spectrum <i>anticonvulsant</i> that acts by blocking <u>T-type calcium channels</u> in thalamic neurons, specifically indicated for the treatment of [[absence_seizure]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks voltage-gated <b>T-type Ca<sup>2+</sup> channels</b> in the [[thalamus]], disrupting the thalamocortical oscillations responsible for absence seizures.</li><li><b>Clinical Use:</b> First-line monotherapy for [[absence_seizure]].</li><li><b>Adverse Effects:</b> GI distress (nausea/vomiting), fatigue, headache, itching, and rarely [[stevens_johnson_syndrome]].</li><li><b>USMLE Tip:</b> Remember \"<b>E</b>thosuximide for <b>E</b>veryone's <b>F</b>avorite <b>G</b>eneralized <b>H</b>eart-throb\" (EFGH: <b>E</b>thosuximide, <b>F</b>atigue, <b>G</b>I distress, <b>H</b>eadache). Or simply: It SUCKS (Etho<b>sux</b>imide) to have Silent Seizures.</li></ul>",
      "takeAway": "<p><b>Ethosuximide</b> is the drug of choice for [[absence_seizure]] because it specifically targets the <mark>T-type calcium channels</mark> in the thalamus that generate the characteristic 3 Hz spike-and-wave rhythm.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "absence_seizure"
      },
      {
        "type": "blocks_channel",
        "to": "t_type_calcium_channel"
      },
      {
        "type": "acts_on_structure",
        "to": "thalamus"
      },
      {
        "type": "can_cause",
        "to": "stevens_johnson_syndrome"
      }
    ]
  },
  "acalculia": {
    "title": "Acalculia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "Cognition",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Agnosias"
    ],
    "content": {
      "definition": "<p><b>Acalculia</b> is an acquired neurological deficit characterized by the <u>inability to perform simple mathematical calculations</u>, classically associated with lesions to the <b>dominant parietal lobe</b> (specifically the angular gyrus).</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dominant (usually Left) [[parietal_lobe]] (Angular Gyrus).</li><li><b>Associations:</b> A core component of [[gerstmann_syndrome]] (along with agraphia, finger agnosia, and left-right disorientation).</li><li><b>Etiology:</b> Stroke (e.g., [[middle_cerebral_artery]] infarct), tumor, or neurodegeneration.</li><li><b>USMLE Tip:</b> If a patient cannot subtract 7 from 100 serially and has right-left confusion, suspect a dominant parietal lesion.</li></ul>",
      "takeAway": "<p><b>Acalculia</b> is a localizing sign for <b>dominant parietal lobe</b> dysfunction, most famously as part of the tetrad of [[gerstmann_syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "gerstmann_syndrome"
      },
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      },
      {
        "type": "caused_by_infarct_of",
        "to": "middle_cerebral_artery"
      }
    ]
  },
  "accessory_nerve": {
    "title": "Accessory Nerve (CN XI)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN XI"
    ],
    "content": {
      "definition": "<p>The <b>Accessory Nerve (CN XI)</b> is a purely motor cranial nerve that originates from the upper cervical spinal cord, enters the skull via the foramen magnum, and exits via the [[jugular_foramen]] to innervate the <b>sternocleidomastoid</b> (SCM) and <b>trapezius</b> muscles.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Head turning (SCM) and shoulder shrugging (Trapezius).</li><li><b>Course:</b> Spinal roots C1-C5 &rarr; Foramen Magnum &rarr; Jugular Foramen &rarr; Muscles.</li><li><b>Lesion Findings:</b> <br> - <b>LMN Lesion:</b> Ipsilateral shoulder droop (weak trapezius), difficulty turning head to the <u>contralateral</u> side (weak ipsilateral SCM).<br> - <b>Winged Scapula:</b> Can occur (lateral winging) but distinct from Long Thoracic Nerve injury (medial winging).</li><li><b>USMLE Tip:</b> To test the <b>Right</b> SCM, the patient turns their head to the <b>Left</b>. A Right CN XI lesion causes weakness turning head to the Left.</li></ul>",
      "takeAway": "<p><b>CN XI</b> is unique for its spinal origin and cranial exit; damage results in ipsilateral shoulder weakness and difficulty turning the head away from the lesion.</p>",
      "mermaid": "graph TD; A[C1-C5 Spinal Roots] --> B[Foramen Magnum]; B --> C[Jugular Foramen]; C --> D[Sternocleidomastoid]; C --> E[Trapezius];"
    },
    "connections": [
      {
        "type": "innervates",
        "to": "sternocleidomastoid_muscle"
      },
      {
        "type": "innervates",
        "to": "trapezius_muscle"
      },
      {
        "type": "exits_via",
        "to": "jugular_foramen"
      },
      {
        "type": "lesion_causes",
        "to": "shoulder_droop"
      }
    ]
  },
  "accommodation_reflex": {
    "title": "Accommodation Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Accommodation Reflex</b> is the visual response to focusing on a near object, characterized by the triad of <b>convergence</b>, <b>miosis</b> (pupillary constriction), and <b>lens thickening</b> (accommodation), mediated by the parasympathetic fibers of [[oculomotor_nerve]].</p>",
      "atAGlance": "<ul><li><b>Triad:</b><br> 1. <b>Convergence:</b> Medial recti contraction (CN III).<br> 2. <b>Miosis:</b> Sphincter pupillae contraction (CN III parasympathetics) to increase depth of field.<br> 3. <b>Accommodation:</b> Ciliary muscle contraction &rarr; Zonules relax &rarr; Lens rounds up (increases refractive power).</li><li><b>Pathway:</b> Retina &rarr; Optic Nerve &rarr; LGN &rarr; Visual Cortex &rarr; Superior Colliculus/Pretectum &rarr; Edinger-Westphal Nucleus &rarr; Ciliary Ganglion &rarr; Eye.</li><li><b>Clinical Relevance:</b> <b>Argyll Robertson Pupil</b> (Neurosyphilis) shows \"Light-Near Dissociation\" (pupils accommodate but do not react to light).</li><li><b>USMLE Tip:</b> Ciliary muscle <u>contraction</u> leads to zonule <u>relaxation</u>. This is counterintuitive but critical.</li></ul>",
      "takeAway": "<p><b>Accommodation</b> allows for near vision through a coordinated parasympathetic response that rounds the lens, constricts the pupil, and converges the eyes; this reflex can be spared in pathways affecting the light reflex (Light-Near Dissociation).</p>",
      "mermaid": "graph TD; A[Visual Cortex] --> B[Edinger-Westphal Nucleus]; B -->|CN III Parasympathetic| C[Ciliary Ganglion]; C --> D[Sphincter Pupillae (Miosis)]; C --> E[Ciliary Muscle (Lens Rounding)];"
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "oculomotor_nerve"
      },
      {
        "type": "involves_structure",
        "to": "ciliary_muscle"
      },
      {
        "type": "is_spared_in",
        "to": "argyll_robertson_pupil"
      },
      {
        "type": "results_in",
        "to": "miosis"
      }
    ]
  },
  "acetazolamide": {
    "title": "Acetazolamide",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Nephrology",
      "Ophthalmology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Diuretics",
      "Carbonic Anhydrase Inhibitors"
    ],
    "content": {
      "definition": "<p><b>Acetazolamide</b> is a <i>carbonic anhydrase inhibitor</i> that acts primarily in the <u>proximal convoluted tubule</u> of the kidney to inhibit HCO<sub>3</sub><sup>-</sup> reabsorption, causing a metabolic acidosis and diuresis, while also reducing aqueous humor and CSF production.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Inhibits carbonic anhydrase &rarr; Decreased H<sup>+</sup> secretion &rarr; Increased Na<sup>+</sup>/K<sup>+</sup>/HCO<sub>3</sub><sup>-</sup> excretion.</li><li><b>Clinical Uses:</b> [[glaucoma]] (decreases aqueous humor), [[idiopathic_intracranial_hypertension]] (decreases CSF), [[altitude_sickness]] (metabolic acidosis stimulates respiration), metabolic alkalosis.</li><li><b>Adverse Effects:</b> <b>Proximal Renal Tubular Acidosis (Type 2)</b>, paresthesias, NH<sub>3</sub> toxicity, sulfa allergy, hypokalemia, kidney stones (calcium phosphate).</li><li><b>USMLE Tip:</b> \"ACID-azolamide\" causes <b>Acidosis</b>. Useful for alkalinizing urine (e.g., to excrete uric acid/cystine) but contraindicated in cirrhosis (traps ammonia).</li></ul>",
      "takeAway": "<p><b>Acetazolamide</b> is a diuretic that uniquely causes <mark>metabolic acidosis</mark> by dumping bicarbonate, making it useful for altitude sickness and glaucoma, but risking Type 2 RTA.</p>",
      "mermaid": "graph TD; A[Acetazolamide] --|Inhibits| B[Carbonic Anhydrase]; B --> C[Decreased H+ Formation]; C --> D[Decreased Na+/H+ Exchange]; D --> E[Increased HCO3- Excretion]; E --> F[Metabolic Acidosis];"
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "treats",
        "to": "idiopathic_intracranial_hypertension"
      },
      {
        "type": "treats",
        "to": "altitude_sickness"
      },
      {
        "type": "causes",
        "to": "renal_tubular_acidosis"
      }
    ]
  },
  "acetylcholine": {
    "title": "Acetylcholine (ACh)",
    "primaryType": "substance",
    "tags": [
      "Neuroscience",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Neurotransmitters",
      "Cholinergics"
    ],
    "content": {
      "definition": "<p><b>Acetylcholine (ACh)</b> is a major neurotransmitter synthesized from choline and acetyl-CoA that acts on <u>nicotinic</u> (ligand-gated ion channels) and <u>muscarinic</u> (G-protein coupled) receptors to mediate motor control, autonomic functions, and cognition.</p>",
      "atAGlance": "<ul><li><b>Sites of Action:</b><br> 1. <b>NMJ:</b> Somatic motor neurons (Nicotinic).<br> 2. <b>Autonomic Ganglia:</b> Both Sympathetic and Parasympathetic (Nicotinic).<br> 3. <b>Parasympathetic Effectors:</b> Smooth muscle, glands, heart (Muscarinic).<br> 4. <b>CNS:</b> Basal nucleus of Meynert (Cognition/Memory).</li><li><b>Synthesis/Degradation:</b> Made by Choline Acetyltransferase (ChAT); degraded by [[acetylcholinesterase]] (AChE).</li><li><b>Pathology:</b> Decreased in [[alzheimer_disease]] and [[huntington_disease]]; Increased in [[parkinson_disease]] (relative to dopamine).</li><li><b>USMLE Tip:</b> In the Sympathetic NS, ACh is the neurotransmitter at the ganglion AND at the <b>Sweat Glands</b> (muscarinic) and <b>Adrenal Medulla</b> (nicotinic).</li></ul>",
      "takeAway": "<p><b>Acetylcholine</b> is the primary neurotransmitter of the parasympathetic nervous system and the neuromuscular junction; its levels are critically reduced in [[alzheimer_disease]] and targeted by AChE inhibitors.</p>",
      "mermaid": "graph TD; A[Choline + Acetyl-CoA] -->|ChAT| B[Acetylcholine]; B -->|Release| C[Synaptic Cleft]; C -->|AChE| D[Choline + Acetate]; C --> E[Nicotinic/Muscarinic Receptors];"
    },
    "connections": [
      {
        "type": "binds_to",
        "to": "nicotinic_acetylcholine_receptor"
      },
      {
        "type": "binds_to",
        "to": "muscarinic_acetylcholine_receptor"
      },
      {
        "type": "is_degraded_by",
        "to": "acetylcholinesterase"
      },
      {
        "type": "is_deficient_in",
        "to": "alzheimer_disease"
      }
    ]
  },
  "achilles_reflex": {
    "title": "Achilles Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Deep Tendon Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Achilles Reflex</b> (Ankle Jerk) is a deep tendon reflex mediated by the <u>S1 and S2</u> nerve roots (primarily S1), where striking the Achilles tendon causes plantar flexion of the foot.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> <b>S1</b>, S2.</li><li><b>Nerve:</b> [[tibial_nerve]].</li><li><b>Action:</b> Plantar flexion of the foot via the gastrocnemius/soleus muscles.</li><li><b>Clinical Significance:</b><br> - <i>Decreased/Absent:</i> S1 radiculopathy (e.g., herniated disc), peripheral neuropathy (e.g., diabetes), [[guillain_barre_syndrome]].<br> - <i>Delayed Relaxation:</i> Classic sign of [[hypothyroidism]].</li><li><b>USMLE Tip:</b> Mnemonic: \"S1, S2, buckle my shoe\" (Achilles reflex).</li></ul>",
      "takeAway": "<p>The <b>Achilles Reflex</b> primarily tests the integrity of the <b>S1</b> nerve root and the tibial nerve; loss suggests pathology at this level or peripheral neuropathy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "s1_nerve_root"
      },
      {
        "type": "mediated_by",
        "to": "tibial_nerve"
      },
      {
        "type": "is_delayed_in",
        "to": "hypothyroidism"
      }
    ]
  },
  "action_potential": {
    "title": "Action Potential",
    "primaryType": "process",
    "tags": [
      "Physiology",
      "Neuroscience",
      "USMLE"
    ],
    "classificationPath": [
      "Physiology",
      "Cell Physiology",
      "Electrophysiology"
    ],
    "content": {
      "definition": "<p>An <b>Action Potential</b> is a rapid, transient, and regenerative <i>change in membrane potential</i> that propagates along an excitable membrane (neuron or muscle), driven by the sequential opening and closing of voltage-gated <u>sodium</u> and <u>potassium</u> channels.</p>",
      "atAGlance": "<ul><li><b>Phases:</b><br> 0. <b>Depolarization:</b> Voltage-gated Na<sup>+</sup> channels open (Na<sup>+</sup> influx).<br> 1. <b>Repolarization:</b> Na<sup>+</sup> channels inactivate, Voltage-gated K<sup>+</sup> channels open (K<sup>+</sup> efflux).<br> 2. <b>Hyperpolarization:</b> K<sup>+</sup> channels remain open, membrane potential dips below resting.</li><li><b>Threshold:</b> All-or-none principle (usually -55 mV).</li><li><b>Refractory Periods:</b><br> - <i>Absolute:</i> Na<sup>+</sup> channels inactivated (no new AP possible).<br> - <i>Relative:</i> Na<sup>+</sup> channels reset but K<sup>+</sup> efflux continues (requires stronger stimulus).</li><li><b>USMLE Tip:</b> [[tetrodotoxin]] (Pufferfish) blocks Na<sup>+</sup> channels (prevents depolarization). [[tetraethylammonium]] blocks K<sup>+</sup> channels (prolongs repolarization).</li></ul>",
      "takeAway": "<p>The <b>Action Potential</b> is the fundamental unit of neural communication, driven by Na<sup>+</sup> influx (depolarization) followed by K<sup>+</sup> efflux (repolarization), a sequence targeted by numerous toxins and anesthetics.</p>",
      "mermaid": "graph TD; A[Resting Potential] -->|Stimulus| B[Threshold Reached]; B -->|Na+ Channels Open| C[Depolarization]; C -->|Na+ Inactivate / K+ Open| D[Repolarization]; D -->|K+ Slow Close| E[Hyperpolarization]; E -->|Na+/K+ Pump| A;"
    },
    "connections": [
      {
        "type": "driven_by",
        "to": "voltage_gated_sodium_channel"
      },
      {
        "type": "driven_by",
        "to": "voltage_gated_potassium_channel"
      },
      {
        "type": "inhibited_by",
        "to": "tetrodotoxin"
      },
      {
        "type": "inhibited_by",
        "to": "local_anesthetics"
      }
    ]
  },
  "acute_disseminated_encephalomyelitis": {
    "title": "Acute Disseminated Encephalomyelitis (ADEM)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Demyelinating Diseases",
      "Post-Infectious"
    ],
    "content": {
      "definition": "<p><b>Acute Disseminated Encephalomyelitis (ADEM)</b> is an acute, monophasic <i>inflammatory demyelinating disorder</i> of the CNS that typically occurs <u>following a viral infection or vaccination</u>, characterized by multifocal neurologic deficits and altered mental status.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Molecular mimicry leads to autoimmune demyelination.</li><li><b>Clinical Presentation:</b> Rapid onset of multifocal deficits (e.g., ataxia, weakness, vision loss) + <b>Encephalopathy</b> (confusion/coma) occurring 1-2 weeks post-infection (e.g., Measles, VZV) or vaccination.</li><li><b>Imaging:</b> MRI shows multiple, asymmetric, hyperintense white matter lesions.</li><li><b>Differentiation:</b> Unlike [[multiple_sclerosis]], ADEM is typically <b>monophasic</b> (one-time event) and involves encephalopathy.</li><li><b>USMLE Tip:</b> Look for a child with neurologic symptoms weeks after a viral illness or vaccine (e.g., Rabies vaccine).</li></ul>",
      "takeAway": "<p><b>ADEM</b> is a post-infectious autoimmune attack on CNS myelin, distinguished from MS by its monophasic course and the presence of altered mental status (encephalopathy).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_triggered_by",
        "to": "viral_infection"
      },
      {
        "type": "is_contrasted_with",
        "to": "multiple_sclerosis"
      },
      {
        "type": "causes",
        "to": "demyelination"
      }
    ]
  },
  "acute_inflammatory_demyelinating_polyneuropathy": {
    "title": "Acute Inflammatory Demyelinating Polyneuropathy (AIDP)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Neuropathy",
      "Guillain-Barre Syndrome"
    ],
    "content": {
      "definition": "<p><b>Acute Inflammatory Demyelinating Polyneuropathy (AIDP)</b> is the most common subtype of [[guillain_barre_syndrome]], characterized by an acute, ascending, symmetrical <i>autoimmune demyelination</i> of peripheral nerves and roots, often triggered by a preceding infection.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Molecular mimicry (e.g., anti-ganglioside antibodies) following infection (classically [[campylobacter_jejuni]], Zika, CMV) leads to immune attack on Schwann cells/myelin.</li><li><b>Clinical Presentation:</b> Symmetric <b>ascending muscle weakness</b>/paralysis, absent deep tendon reflexes (areflexia), and potential autonomic dysregulation or respiratory failure.</li><li><b>Diagnosis:</b> CSF shows <mark>albuminocytologic dissociation</mark> (high protein, normal WBC). Nerve conduction studies show slowed conduction (demyelination).</li><li><b>Treatment:</b> IVIG or Plasmapheresis. <u>Steroids are NOT effective.</u></li><li><b>USMLE Tip:</b> \"Ascending paralysis\" after bloody diarrhea ([[campylobacter_jejuni]]) is the classic vignette. Watch for respiratory failure (measure Vital Capacity).</li></ul>",
      "takeAway": "<p><b>AIDP</b> is the classic form of Guillain-Barr√©, presenting as an ascending paralysis with areflexia and albuminocytologic dissociation, requiring urgent monitoring for respiratory compromise.</p>",
      "mermaid": "graph TD; A[Infection e.g. Campylobacter] --> B[Antibody Production]; B --> C[Cross-reactivity with Gangliosides]; C --> D[Attack on Schwann Cells]; D --> E[Peripheral Demyelination]; E --> F[Ascending Paralysis];"
    },
    "connections": [
      {
        "type": "is_synonymous_with",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "triggered_by",
        "to": "campylobacter_jejuni"
      },
      {
        "type": "diagnosed_by",
        "to": "albuminocytologic_dissociation"
      },
      {
        "type": "damages_cell_type",
        "to": "schwann_cells"
      }
    ]
  },
  "adenohypophysis": {
    "title": "Adenohypophysis (Anterior Pituitary)",
    "primaryType": "structure",
    "tags": [
      "Endocrinology",
      "Anatomy",
      "Embryology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrinology",
      "Pituitary Gland",
      "Anterior Lobe"
    ],
    "content": {
      "definition": "<p>The <b>Adenohypophysis</b> is the glandular anterior lobe of the [[pituitary_gland]], derived from oral ectoderm ([[rathke_pouch]]), which synthesizes and secretes six major hormones in response to hypothalamic releasing factors delivered via the hypophyseal portal system.</p>",
      "atAGlance": "<ul><li><b>Embryology:</b> Derived from <b>Rathke's Pouch</b> (surface ectoderm), unlike the neurohypophysis (neuroectoderm).</li><li><b>Hormones (FLAT PiG):</b> <b>F</b>SH, <b>L</b>H, <b>A</b>CTH, <b>T</b>SH (Basophils); <b>P</b>rolactin, <b>G</b>H (Acidophils).</li><li><b>Regulation:</b> Controlled by the [[hypothalamus]] via the hypophyseal portal system (blood), not direct neural connection.</li><li><b>Pathology:</b> [[pituitary_adenoma]] (e.g., Prolactinoma), [[sheehan_syndrome]] (ischemic necrosis post-partum), [[craniopharyngioma]] (Rathke's pouch remnant).</li><li><b>USMLE Tip:</b> Acidophils (GH, Prolactin) stain pink; Basophils (FSH, LH, ACTH, TSH) stain blue. \"B-FLAT\".</li></ul>",
      "takeAway": "<p>The <b>Adenohypophysis</b> is the master glandular center derived from oral ectoderm, regulating growth, metabolism, and reproduction through the secretion of tropic hormones under hypothalamic vascular control.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "derived_from",
        "to": "rathke_pouch"
      },
      {
        "type": "secretes",
        "to": "prolactin"
      },
      {
        "type": "secretes",
        "to": "growth_hormone"
      },
      {
        "type": "regulated_by",
        "to": "hypothalamus"
      }
    ]
  },
  "adenovirus": {
    "title": "Adenovirus",
    "primaryType": "organism",
    "tags": [
      "Microbiology",
      "Virology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Microbiology",
      "Viruses",
      "DNA Viruses",
      "Non-enveloped"
    ],
    "content": {
      "definition": "<p><b>Adenovirus</b> is a non-enveloped, double-stranded linear DNA virus responsible for a wide range of clinical syndromes, most notably pharyngoconjunctival fever, pneumonia, and hemorrhagic cystitis.</p>",
      "atAGlance": "<ul><li><b>Transmission:</b> Respiratory droplets, fecal-oral, direct contact (fomites). Highly stable in the environment.</li><li><b>Clinical Syndromes:</b><br> - <b>Pharyngoconjunctival Fever:</b> Fever + Sore throat + [[conjunctivitis]] (\"Pink eye\").<br> - <b>Pneumonia:</b> Especially in military recruits (vaccine available for military).<br> - <b>Hemorrhagic Cystitis:</b> Hematuria and dysuria in children.<br> - <b>Gastroenteritis:</b> Watery diarrhea.</li><li><b>Histology:</b> Intranuclear inclusions.</li><li><b>USMLE Tip:</b> Look for a child with \"Pink eye\" after swimming (swimming pool conjunctivitis) or a military recruit with pneumonia.</li></ul>",
      "takeAway": "<p><b>Adenovirus</b> is a hardy DNA virus that causes outbreaks of conjunctivitis, respiratory illness (military recruits), and hemorrhagic cystitis in children.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "conjunctivitis"
      },
      {
        "type": "causes",
        "to": "hemorrhagic_cystitis"
      },
      {
        "type": "causes",
        "to": "pneumonia"
      }
    ]
  },
  "adrenoleukodystrophy": {
    "title": "Adrenoleukodystrophy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Genetics",
      "Metabolism",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Demyelinating Diseases",
      "Leukodystrophies"
    ],
    "content": {
      "definition": "<p><b>Adrenoleukodystrophy</b> is an X-linked recessive <i>peroxisomal disorder</i> caused by a mutation in the <i>ABCD1</i> gene, leading to impaired <u>beta-oxidation of very-long-chain fatty acids (VLCFAs)</u>, which accumulate in and damage the adrenal glands and CNS myelin.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Defective transport of VLCFAs into peroxisomes &rarr; Accumulation of VLCFAs &rarr; Toxicity to adrenal cortex and white matter.</li><li><b>Clinical Presentation:</b> Progressive neurologic deterioration (dementia, vision loss, ataxia) + [[adrenal_insufficiency]] (skin hyperpigmentation, hypotension) in young boys.</li><li><b>Genetics:</b> X-linked recessive.</li><li><b>Diagnosis:</b> Elevated VLCFAs in plasma.</li><li><b>USMLE Tip:</b> Think of this when a young boy presents with behavioral changes/school failure AND signs of Addison disease (tan skin, low Na, high K).</li></ul>",
      "takeAway": "<p><b>Adrenoleukodystrophy</b> is a peroxisomal disease of VLCFA accumulation that uniquely combines progressive CNS demyelination with primary adrenal insufficiency.</p>",
      "mermaid": "graph TD; A[ABCD1 Mutation] --> B[Impaired Peroxisomal Entry]; B --> C[Accumulation of VLCFAs]; C --> D[Adrenal Gland Damage]; C --> E[CNS Demyelination]; D --> F[Adrenal Insufficiency]; E --> G[Neurologic Deterioration];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "adrenal_insufficiency"
      },
      {
        "type": "involves_organelle",
        "to": "peroxisome"
      },
      {
        "type": "accumulates",
        "to": "very_long_chain_fatty_acids"
      }
    ]
  },
  "age_related_macular_degeneration": {
    "title": "Age-Related Macular Degeneration (AMD)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Aging",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Disorders",
      "Macular Degeneration"
    ],
    "content": {
      "definition": "<p><b>Age-Related Macular Degeneration (AMD)</b> is the leading cause of irreversible <u>central vision loss</u> in the elderly, characterized by the degeneration of the macula due to oxidative stress and the accumulation of extracellular deposits called <b>drusen</b>.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>Dry (Non-exudative):</b> Gradual vision loss; characterized by subretinal <mark>drusen</mark> (yellow deposits) and pigmentary changes. Most common (85%).<br> - <b>Wet (Exudative):</b> Rapid vision loss; characterized by <u>choroidal neovascularization</u> (VEGF-driven) leading to bleeding/leakage.</li><li><b>Clinical:</b> Central scotoma (loss of central vision), metamorphopsia (distortion of straight lines).</li><li><b>Treatment:</b><br> - Dry: Antioxidant vitamins (AREDS), smoking cessation.<br> - Wet: Anti-VEGF injections (e.g., [[ranibizumab]], [[bevacizumab]]).</li><li><b>USMLE Tip:</b> \"Metamorphopsia\" (wavy lines on Amsler grid) suggests Wet AMD. Peripheral vision is preserved (unlike [[glaucoma]]).</li></ul>",
      "takeAway": "<p><b>AMD</b> destroys central vision (macula) while sparing peripheral vision; Dry AMD involves <b>drusen</b>, while Wet AMD involves <b>neovascularization</b> treatable with anti-VEGF therapy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "central_scotoma"
      },
      {
        "type": "characterized_by",
        "to": "drusen"
      },
      {
        "type": "treated_by",
        "to": "anti_vegf_therapy"
      },
      {
        "type": "is_contrasted_with",
        "to": "glaucoma"
      }
    ]
  },
  "agraphia": {
    "title": "Agraphia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Agraphia</b> is an acquired neurological deficit characterized by the <u>inability to write</u> or communicate through writing, often resulting from lesions in the dominant parietal lobe or frontal lobe language centers.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dominant [[parietal_lobe]] (Angular Gyrus) or Frontal Lobe (Exner's area).</li><li><b>Associations:</b> A core component of [[gerstmann_syndrome]] (Agraphia + Acalculia + Finger Agnosia + Left-Right Disorientation).</li><li><b>Context:</b> Can occur in isolation or with aphasia (e.g., [[broca_aphasia]] patients have agraphia matching their speech deficits).</li><li><b>USMLE Tip:</b> Agraphia without aphasia points strongly to the dominant angular gyrus (Gerstmann Syndrome).</li></ul>",
      "takeAway": "<p><b>Agraphia</b> is the loss of writing ability, serving as a key localizing sign for dominant parietal lobe pathology, particularly when grouped with the other elements of [[gerstmann_syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "gerstmann_syndrome"
      },
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      },
      {
        "type": "is_associated_with",
        "to": "aphasia"
      }
    ]
  },
  "akathisia": {
    "title": "Akathisia",
    "primaryType": "finding",
    "tags": [
      "Psychiatry",
      "Neurology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Drug-Induced"
    ],
    "content": {
      "definition": "<p><b>Akathisia</b> is an extrapyramidal symptom characterized by a subjective feeling of inner restlessness and an objective <u>inability to sit still</u> (e.g., pacing, tapping feet), most commonly caused by [[antipsychotics]] blocking dopamine receptors.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> High-potency typical [[antipsychotics]] (e.g., [[haloperidol]]) or antiemetics (e.g., [[metoclopramide]]).</li><li><b>Timeline:</b> Days to weeks after starting medication.</li><li><b>Differentiation:</b> Often mistaken for worsening agitation/psychosis (leading to increased drug dose, worsening the akathisia).</li><li><b>Treatment:</b> Decrease dose, switch to atypical, or treat with <b>Beta-blockers</b> ([[propranolol]]) or Benzodiazepines. Benztropine is less effective here than for dystonia.</li><li><b>USMLE Tip:</b> Patient on Haloperidol feels \"jumping out of their skin\" and keeps pacing the room. Treat with Propranolol.</li></ul>",
      "takeAway": "<p><b>Akathisia</b> is a drug-induced motor restlessness often misdiagnosed as anxiety; unlike other EPS, it responds best to beta-blockers ([[propranolol]]) rather than anticholinergics.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "antipsychotics"
      },
      {
        "type": "treated_by",
        "to": "propranolol"
      },
      {
        "type": "is_a_type_of",
        "to": "extrapyramidal_symptoms"
      }
    ]
  }
}